NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
88 hedge funds and large institutions have $1.12B invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 30
Holders
88
Holding in Top 10
7
Calls
$651K
Puts
–
Top Buyers
| 1 | +$9.38M | |
| 2 | +$5.02M | |
| 3 | +$4.52M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.35M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.79M |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.31M | |
| 3 | -$1.1M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.06M |
| 5 |
Two Sigma Investments
New York
|
-$788K |